Clorox Stock News

Over the last five months, high-beta stocks (typically considered growth stocks) have rocketed 46% higher, while low-volatility stocks (think value stocks, like staple goods) have remained flat.

The Clorox Company (CLX) has declined 26% over the past year despite broader market gains. CLX offers a 4% dividend yield, attracting investors seeking stable, defensive stocks. The company faces growth headwinds and stagnation, trading at a 20% premium to industry peers.

OAKLAND, Calif. , Sept. 16, 2025 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared a quarterly dividend of $1.24 per share on the company's common stock.

The Clorox Company is rated 'Hold' as current valuation fully reflects its fair value and limited near-term growth prospects. CLX faces a temporary decline in FY2026 sales and profits due to one-time ERP-related shipment effects and inventory normalization. Despite strong brands, stable dividends, and moderate buybacks, CLX trades at a premium with no significant upside absent new growth drivers.

Many retail investors fear selloffs. But if you know where to look, pullbacks can be your best friend.

The Clorox Company (NYSE:CLX ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 3, 2025 7:30 AM EDT Company Participants Linda Rendle - CEO & Chairman Luc Bellet - Executive VP & CFO Conference Call Participants Lauren Lieberman - Barclays Bank PLC, Research Division Presentation Lauren Lieberman MD & Senior Research Analyst Okay. We're going to get started.

First-of-its-kind Screen+ Sanitizing Wipes offer hi-tech hygiene for today's facilities and shared workspaces. OAKLAND, Calif.

Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 Aristocrats raising payouts in 2025 and an average growth rate of 5.14%, signaling continued income reliability. My 'Promising Aristocrats' list, focused on undervaluation and projected total return...